Target intelligence / Profile preview

Ribosomal protein L39 pseudogene 26 (RPL39P26)

Target
RPL39P26
Molecular classification
Other (pseudogene)
01

Overview

Ribosomal protein L39 pseudogene 26 (RPL39P26) is a pseudogene in the human genome. Pseudogenes are segments of DNA that are similar to known genes but are non-functional; they do not encode functional proteins. RPL39P26 is related in sequence to the gene encoding ribosomal protein L39 but does not produce a functional product and has no known biological activity or disease association[1][4][7]. RPL39P26 is specifically annotated as a pseudogene, not as a functional coding gene, enzyme, receptor, or any other recognized drug target category[1][4][7]. There is no evidence in available gene or protein databases that it encodes any active protein, is involved in biological pathways, or is therapeutically relevant (i.e., not a receptor, enzyme, transporter, transcription factor, etc.)[1][4][7]. Its only direct alias found is RPL39_12_1121[4]. The canonical ribosomal protein L39 (RPL39) is distinct and functional, but RPL39P26 is one of many non-coding pseudogene copies[1][2][3][7]. RPL39P26 is not a true molecular target; it is a pseudogene with no known function, therapeutic implication, or drug interactions, so this entry is most likely incorrect as a target for drug discovery or biomarker research[1][4][7].

Other names
RPL39_12_1121

Beyond the preview

Go deeper on Ribosomal protein L39 pseudogene 26 (RPL39P26).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L39 pseudogene 26 (RPL39P26).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call